NLRP3 and liver disorder: Utilizing advances in molecular biology, that provide novel gene therapy options for experimental treatments in liver disease and hepatic surgery, they were able, in addition, to observe that gene silencing of NLRP3 via shRNA plasmid suppressed the activation of hepatic caspase-1, protecting against I/R injury [101,102].